Pachamuthu Kandasamy, PhD

Vice President, Medicinal Chemistry at Wave Life Sciences

Speaker

Dr. Kandasamy has over 15 years of experience in oligonucleotide research and development. His work is dedicated to novel chemical modification on oligonucleotides to improve pharmacological properties. He worked on siRNA delivery technologies and contributed to three approved drugs at Alnylam prior to joining Wave Life Sciences in 2016. He earned a Ph.D. in synthetic carbohydrate chemistry focused on discovering new methods for stereospecific anomeric C-O and C-C bond formation related to GalNAc sugars from the Indian Institute of Technology Kanpur (India) before completing postdoctoral work on glycopeptides at the University of Konstanz (Germany) with Professor Richard R. Schmidt and worked on aminoglycosides antibiotics at University of Montreal (Canada) with Professor Stephan Hanessian.